Express News | Fed's Goolsbee Tells CNBC 'nice' to Get Inflation Number That's Better Than Expected
Fennec Pharmaceuticals Brief: Announcing Pedmarqsi "Positive Recommendation" by NICE for Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Fennec Pharmaceuticals Announces Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
NICE Shares Are Trading Lower After Jefferies Downgraded the Stock From Buy to Hold and Cut Its Price Target From $215 to $200.
NICE Cut to Hold From Buy by Jefferies
Express News | Jefferies Downgrades NICE to Hold, Lowers Price Target to $200
NICE Analyst Ratings
Twilio, Nice Among Key Growth Picks in Communication Software, Morgan Stanley Says
P/E Ratio Insights for NICE
Nice Price Target Raised to $246 From $240 at Morgan Stanley
Morgan Stanley Raises Price Target on NICE to $246 From $240, Keeps Overweight Rating
NICE (NICE) Gets a Buy From Morgan Stanley
Glia Doubles Down on Channel and Hires Ray Hicken as Executive Channel Advisor
H.C. Wainwright Calls Pharming 'Nice Stocking Stuffer' After Deal
Outlook Therapeutics Streamlines Operations, Cuts Workforce By 23% For $1.4M Annual Savings, Aims To Launch LYTENAVA In EU/UK, Prepares BLA Resubmission In Q1 2025 Despite NORSE EIGHT Trial Not Meeting Endpoint; LYTENAVA Receives NICE Recommendation,...
NICE Ltd's (NICE) Breakthrough Tech: Transforming the Future of Digital Evidence
Analysts Conflicted on These Technology Names: Broadcom (AVGO), NICE (NICE) and Science Applications (SAIC)
Get Nice Financial Posts Lower Fiscal H1 Profit
Express News | NICE Shares Are Trading Higher After the Company Announced Calcasieu Parish District Attorney's Office Selected NICE Justice to Safeguard and Streamline Its Digital Evidence Management
I Sold Nvidia—then It Went up Over 28,000%, Says Behavioral Finance Prof: I Could've Bought 'a Nice House...
No Data